BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26485036)

  • 1. Current status and future directions of pharmacological therapy for acromegaly.
    Mercado M; Espinosa E; Ramírez C
    Minerva Endocrinol; 2016 Sep; 41(3):351-65. PubMed ID: 26485036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological therapy for acromegaly: a critical review.
    Muller AF; Van Der Lely AJ
    Drugs; 2004; 64(16):1817-38. PubMed ID: 15301564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of pituitary adenomas.
    Chanson P; Salenave S
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological management of acromegaly: a current perspective.
    Manjila S; Wu OC; Khan FR; Khan MM; Arafah BM; Selman WR
    Neurosurg Focus; 2010 Oct; 29(4):E14. PubMed ID: 20887124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 60 YEARS OF NEUROENDOCRINOLOGY: Acromegaly.
    Capatina C; Wass JA
    J Endocrinol; 2015 Aug; 226(2):T141-60. PubMed ID: 26136383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acromegaly: a review of current medical therapy and new drugs on the horizon.
    Fleseriu M; Delashaw JB; Cook DM
    Neurosurg Focus; 2010 Oct; 29(4):E15. PubMed ID: 20887125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current management of acromegaly.
    Díez JJ; Iglesias P
    Expert Opin Pharmacother; 2000 Jul; 1(5):991-1006. PubMed ID: 11249504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of endocrine disease: GH excess: diagnosis and medical therapy.
    Andersen M
    Eur J Endocrinol; 2014 Jan; 170(1):R31-41. PubMed ID: 24144967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy or surgery as primary treatment for acromegaly?
    Ferone D; Colao A; van der Lely AJ; Lamberts SW
    Drugs Aging; 2000 Aug; 17(2):81-92. PubMed ID: 10984197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy and tolerability of somatostatin analogs and other therapies for acromegaly.
    Burt MG; Ho KK
    Endocrine; 2003 Apr; 20(3):299-305. PubMed ID: 12721511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current treatment guidelines for acromegaly.
    Melmed S; Jackson I; Kleinberg D; Klibanski A
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2646-52. PubMed ID: 9709926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
    Karavitaki N; Turner HE; Adams CB; Cudlip S; Byrne JV; Fazal-Sanderson V; Rowlers S; Trainer PJ; Wass JA
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):970-5. PubMed ID: 18031313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Novel pharmacologic therapies in acromegaly].
    Góth M; Hubina E; Kovács L; Szabolcs I
    Orv Hetil; 2002 May; 143(19 Suppl):1057-62. PubMed ID: 12063860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The place of pegvisomant in the acromegaly treatment algorithm.
    Paisley AN; Trainer PJ; Drake WM
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S101-6. PubMed ID: 15135788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of pituitary adenomas].
    Mezosi E; Nemes O
    Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
    Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
    Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing paradigms in the surgical and medical management of acromegaly.
    Stoller WA
    Expert Rev Anticancer Ther; 2006 Sep; 6 Suppl 9():S47-53. PubMed ID: 17004857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
    Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T
    Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy for the syndromes of GH excess.
    Arosio M; Cannavò S; Epaminonda P; Ronchi C; Chiodini I; Adda G
    J Endocrinol Invest; 2003; 26(10 Suppl):36-43. PubMed ID: 15497658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide as primary therapy for acromegaly.
    Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.